Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2E)-2-(2,5-bis[2-[4-(trifluoromethyl)phenyl]ethoxy]benzylidene)hexanoic acid | - |
Homo sapiens | |
(2E)-2-(2,5-bis[[4-(trifluoromethyl)benzyl]oxy]benzylidene)hexanoic acid | 55.1% residual activity at 0.01 mM | Homo sapiens | |
(2E)-2-[2,5-bis(2-cyclohexylethoxy)benzylidene]hexanoic acid | - |
Homo sapiens | |
(2E)-2-[2,5-bis(2-phenylethoxy)benzylidene]hexanoic acid | - |
Homo sapiens | |
(2E)-2-[5-(2-cyclohexylethoxy)-2-[[4-(trifluoromethyl)benzyl]oxy]benzylidene]hexanoic acid | 74% residual activity at 0.01 mM | Homo sapiens | |
2-(2,3-diphenethoxybenzylidene)hexanoic acid | - |
Homo sapiens | |
2-(3,5-diphenethoxybenzyl)hexanoic acid | - |
Homo sapiens | |
2-(3,5-diphenethoxybenzylidene)hexanoic acid | - |
Homo sapiens | |
2-([4,6-bis[2-(4-cyanophenyl)ethoxy]pyrimidin-2-yl]sulfanyl)hexanoic acid | - |
Homo sapiens | |
2-([4,6-bis[2-(4-methoxyphenyl)ethoxy]pyrimidin-2-yl]sulfanyl)hexanoic acid | 63.7% residual activity at 0.01 mM | Homo sapiens | |
2-([4,6-bis[2-(4-methylphenyl)ethoxy]pyrimidin-2-yl]sulfanyl)hexanoic acid | - |
Homo sapiens | |
2-([4,6-bis[2-(4-nitrophenyl)ethoxy]pyrimidin-2-yl]sulfanyl)hexanoic acid | - |
Homo sapiens | |
2-([4,6-bis[2-(thiophen-3-yl)ethoxy]pyrimidin-2-yl]sulfanyl)hexanoic acid | - |
Homo sapiens | |
2-[(3,5-diphenethoxyphenyl)thio]hexanoic acid | - |
Homo sapiens | |
2-[(4,6-bis[2-[4-(trifluoromethoxy)phenyl]ethoxy]pyrimidin-2-yl)sulfanyl]hexanoic acid | 88.3% residual activity at 0.01 mM | Homo sapiens | |
2-[(4,6-bis[2-[4-(trifluoromethyl)phenyl]ethoxy]pyrimidin-2-yl)sulfanyl]hexanoic acid | - |
Homo sapiens | |
2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid | - |
Homo sapiens | |
2-[2,3-bis(2-phenylethoxy)benzyl]hexanoic acid | - |
Homo sapiens | |
2-[2,4-bis(2-phenylethoxy)benzyl]hexanoic acid | 90.1% residual activity at 0.01 mM | Homo sapiens | |
2-[2,5-bis(2-phenylethoxy)benzyl]hexanoic acid | - |
Homo sapiens | |
2-[3,4-bis(2-phenylethoxy)benzyl]hexanoic acid | - |
Homo sapiens | |
2-[3,5-bis(2-phenylethoxy)phenoxy]hexanoic acid | - |
Homo sapiens | |
2-[[4,6-bis(2-cycloheptylethoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | 62.4% residual activity at 0.01 mM | Homo sapiens | |
2-[[4,6-bis(2-cyclohexylethoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | - |
Homo sapiens | |
2-[[4,6-bis(2-cyclopentylethoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | 90% residual activity at 0.01 mM | Homo sapiens | |
2-[[4,6-bis(2-cyclopropylethoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | - |
Homo sapiens | |
2-[[4,6-bis(2-phenylethoxy)pyrimidin-2-yl]sulfanyl]butanoic acid | - |
Homo sapiens | |
2-[[4,6-bis(2-phenylethoxy)pyrimidin-2-yl]sulfanyl]octanoic acid | - |
Homo sapiens | |
2-[[4,6-bis(3-methylbutoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | 54.5% residual activity at 0.01 mM | Homo sapiens | |
2-[[4,6-bis(3-phenylpropoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | - |
Homo sapiens | |
2-[[4,6-bis(4-phenylbutoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | - |
Homo sapiens | |
2-[[4,6-bis(benzyloxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | - |
Homo sapiens | |
MK-886 | i.e. 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-isopropyl-1H-indol-2-yl)-2,2-dimethylpropanoic acid | Homo sapiens | |
additional information | not inhibited by BWA4C, i.e. (E)-N-hydroxy-N-(3-(3-phenoxyphenyl)-allyl)acetamide | Homo sapiens | |
[[4,6-bis(2-phenylethoxy)pyrimidin-2-yl]sulfanyl](phenyl)acetic acid | - |
Homo sapiens | |
[[4,6-bis(2-phenylethoxy)pyrimidin-2-yl]sulfanyl]acetic acid | 66.4% residual activity at 0.01 mM | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
microsome | - |
Homo sapiens | - |
- |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
A-549 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Prostaglandin H2 | - |
Homo sapiens | Prostaglandin E2 | - |
? |
Synonyms | Comment | Organism |
---|---|---|
microsomal prostaglandin E2 synthase-1 | - |
Homo sapiens |
mPGES-1 | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
glutathione | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0006 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[3,5-bis(2-phenylethoxy)phenoxy]hexanoic acid | |
0.0009 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[[4,6-bis(4-phenylbutoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | |
0.0009 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-([4,6-bis[2-(4-methylphenyl)ethoxy]pyrimidin-2-yl]sulfanyl)hexanoic acid | |
0.0011 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-(2,3-diphenethoxybenzylidene)hexanoic acid | |
0.0012 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | [[4,6-bis(2-phenylethoxy)pyrimidin-2-yl]sulfanyl](phenyl)acetic acid | |
0.0012 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid | |
0.0015 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | (2E)-2-[2,5-bis(2-phenylethoxy)benzylidene]hexanoic acid | |
0.0019 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[(4,6-bis[2-[4-(trifluoromethyl)phenyl]ethoxy]pyrimidin-2-yl)sulfanyl]hexanoic acid | |
0.002 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[[4,6-bis(2-phenylethoxy)pyrimidin-2-yl]sulfanyl]octanoic acid | |
0.0022 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[[4,6-bis(3-phenylpropoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | |
0.0024 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | MK-886 | |
0.0024 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[[4,6-bis(2-cyclohexylethoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | |
0.0024 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[2,5-bis(2-phenylethoxy)benzyl]hexanoic acid | |
0.0024 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-(3,5-diphenethoxybenzyl)hexanoic acid | |
0.0027 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[3,4-bis(2-phenylethoxy)benzyl]hexanoic acid | |
0.0028 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-(3,5-diphenethoxybenzylidene)hexanoic acid | |
0.0034 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | (2E)-2-[2,5-bis(2-cyclohexylethoxy)benzylidene]hexanoic acid | |
0.0035 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | (2E)-2-(2,5-bis[2-[4-(trifluoromethyl)phenyl]ethoxy]benzylidene)hexanoic acid | |
0.0037 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-([4,6-bis[2-(4-nitrophenyl)ethoxy]pyrimidin-2-yl]sulfanyl)hexanoic acid | |
0.0038 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[[4,6-bis(benzyloxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | |
0.0039 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[2,3-bis(2-phenylethoxy)benzyl]hexanoic acid | |
0.0046 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[(3,5-diphenethoxyphenyl)thio]hexanoic acid | |
0.0059 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-([4,6-bis[2-(4-cyanophenyl)ethoxy]pyrimidin-2-yl]sulfanyl)hexanoic acid | |
0.0065 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-([4,6-bis[2-(thiophen-3-yl)ethoxy]pyrimidin-2-yl]sulfanyl)hexanoic acid | |
0.0073 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[[4,6-bis(2-phenylethoxy)pyrimidin-2-yl]sulfanyl]butanoic acid | |
0.0096 | - |
in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[[4,6-bis(2-cyclopropylethoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | |
0.01 | - |
IC50 above 0.01 mM, in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | [[4,6-bis(2-phenylethoxy)pyrimidin-2-yl]sulfanyl]acetic acid | |
0.01 | - |
IC50 above 0.01 mM, in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[(4,6-bis[2-[4-(trifluoromethoxy)phenyl]ethoxy]pyrimidin-2-yl)sulfanyl]hexanoic acid | |
0.01 | - |
IC50 above 0.01 mM, in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-([4,6-bis[2-(4-methoxyphenyl)ethoxy]pyrimidin-2-yl]sulfanyl)hexanoic acid | |
0.01 | - |
IC50 above 0.01 mM, in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[[4,6-bis(2-cycloheptylethoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | |
0.01 | - |
IC50 above 0.01 mM, in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[[4,6-bis(2-cyclopentylethoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | |
0.01 | - |
IC50 above 0.01 mM, in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[[4,6-bis(3-methylbutoxy)pyrimidin-2-yl]sulfanyl]hexanoic acid | |
0.01 | - |
IC50 above 0.01 mM, in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | 2-[2,4-bis(2-phenylethoxy)benzyl]hexanoic acid | |
0.01 | - |
IC50 above 0.01 mM, in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | (2E)-2-(2,5-bis[[4-(trifluoromethyl)benzyl]oxy]benzylidene)hexanoic acid | |
0.01 | - |
IC50 above 0.01 mM, in potassium phosphate buffer (0.1 M, pH 7.4) containing 2.5 mM glutathione, at 4°C | Homo sapiens | (2E)-2-[5-(2-cyclohexylethoxy)-2-[[4-(trifluoromethyl)benzyl]oxy]benzylidene]hexanoic acid |